PODCAST

Cardiology

ReachMD

science & medicine medicine

All Episodes

00:00:00

Setting the Stage of Real-World Data vs RCT

Cardiology ·

2025/02/14

Host: Renato D. Lopes, MD, MHS, PhD The effective management of atrial fibrillation (AF) remains a high priority for many clinicians worldwide because a significant number of people globally who are living with AF are at risk of developing venous thromboembolism (VTE). This makes our understanding and implementation of new findings and clinical trial outcomes that much more important as we develop effective, personalized treatment plans for our patients. Tune in to our micro learning

00:00:00

Implications Associated With Integrating Both...

Cardiology ·

2025/02/14

Guest: Valeria Caso, MD, PhD The effective management of atrial fibrillation (AF) remains a high priority for many clinicians worldwide because a significant number of people globally who are living with AF are at risk of developing venous thromboembolism (VTE). This makes our understanding and implementation of new findings and clinical trial outcomes that much more important as we develop effective, personalized treatment plans for our patients. Tune in to our micro learning course

00:00:00

Patient Case Study: Elderly

Cardiology ·

2025/02/14

Host: Renato D. Lopes, MD, MHS, PhD Guest: Valeria Caso, MD, PhD The effective management of atrial fibrillation (AF) remains a high priority for many clinicians worldwide because a significant number of people globally who are living with AF are at risk of developing venous thromboembolism (VTE). This makes our understanding and implementation of new findings and clinical trial outcomes that much more important as we develop effective, personalized treatment plans for our

00:00:00

Pulmonary Hypertension: Diagnosis, Management, and...

Cardiology ·

2024/12/31

Host: Vallerie V. McLaughlin, MD During a satellite symposium at the AHA 2024 Annual Meeting, experts reviewed the role of novel disease-modifying therapies (DMTs) in treating and managing pulmonary hypertension (PH) and the impact of current PH treatments vs novel DMTs. They also discussed how to identify appropriate patients for DMTs and strategies to customize treatment with risk-based assessments. In addition, highlights from the 7th World Symposium in PH were discussed. Tune in to

00:00:00

The Shifting ATTR-CM Landscape: Early Diagnosis,...

Cardiology ·

2024/12/13

Host: Pablo Garcia-Pavia, MD, PhD Guest: Francesco Cappelli, MD Achieving optimal outcomes in patients with transthyretin amyloid cardiomyopathy (ATTR-CM) remains a challenge as diagnosis is often delayed. Patients have a reduced life expectancy and experience debilitating pain and poor quality of life. Hear from the experts as they review the latest information on new and emerging treatment options for transthyretin amyloidosis and how this condition affects patients with

00:00:00

Implementing the AMA MAPTM Hypertension Program: A...

Cardiology ·

2024/10/07

Host: Brian P. McDonough, MD, FAAFP Guest: Willie Lawrence, MD Since implementing the AMA MAP™ Hypertension quality improvement program at Corewell Health, Dr. Willie Lawrence has been able to identify the factors influencing the institution’s blood pressure control rates and optimize their approach. And now Dr. Lawrence is here with Dr. Brian McDonough to share how the program works and how it’s impacted patient care. Dr. Lawrence is the Executive Sponsor of the AMA MAP™

00:00:00

Implementing a Multidisciplinary Approach to Heart...

Cardiology ·

2024/09/25

Host: Christina Economides, MD Guest: Brian Howard, MD Guest: David N. Kenigsberg, MD, FACC Despite guideline-directed medical therapy, many patients with heart failure will continue to develop worsening symptoms and diminishing quality of life. Baroflex activation therapy (BAT) may be a treatment option for patients with heart failure with reduced ejection fraction. Data show clinical benefit with this treatment approach including long-term symptom improvement and reduction in

00:00:00

Implementing a Successful Barostim Program in the...

Cardiology ·

2024/06/18

Guest: Jessica Griffiths, PA-C Guest: Anna L. Rourke, NP The BeAT-HF clinical trial showed that Barostim plus GDMT resulted in significant and meaningful improvements in exercise capacity, functional status, and quality of life. Learn best practices from advanced practice providers for successfully integrating Barostim into your clinical practice.

00:00:00

Beyond the Surface: The Impact of Psoriasis on...

Cardiology ·

2024/06/13

Guest: John Barbieri, MD, MBA, FAAD Patients with psoriasis die about five years younger than those without the condition, and cardiovascular disease is the leading cause of this premature mortality. Tune in to hear Dr. John Barbieri discuss strategies to identify risk factors and improve cardiovascular disease prevention in patients with psoriasis. Dr. Barbieri is an Assistant Professor of Dermatology at Brigham and Women's Hospital at Harvard Medical School in Boston.

00:00:00

How Artificial Sweeteners Could Be Linked to Heart...

Cardiology ·

2024/06/11

Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: Wilson Tang, MD Many different artificial sweeteners are being consumed by patients; however, this discussion will focus on research around one that has been used in the food industry for a long time, called erythritol. Interestingly, it was found that patients with cardiac problems had the highest levels of erythritol levels in their blood, which prompted further studies on this association. So to learn more about the

00:00:00

Plozasiran (ARO-APOC3) Decreases APOC3 and...

Cardiology ·

2024/04/30

Host: Christie M. Ballantyne, MD, FACP, FACC This program brings you select scientific abstracts and late-breaking results from the recent American College of Cardiology 2024 Scientific Sessions. From clinical trials like PIONEER-AF and VOYAGER PAD to updates on the new guidelines, faculty experts are here to break down ways to advance cardiovascular care for all.

00:00:00

Beyond the Horizon: HELIOS Clinical Trials in ATTR...

Cardiology ·

2024/04/19

Host: Marianna Fontana, MD The HELIOS trials, a groundbreaking phase 3 program, are investigating the potential of vutrisiran, an RNA interference (RNAi) therapy, to combat both hereditary and wild-type ATTR amyloidosis. Building on a successful phase 1 study demonstrating vutrisiran's safety and effectiveness in reducing serum TTR, HELIOS is paving the way for a new era in ATTR treatment. Join Dr. Marianna Fontana as she highlights the cardiac exploratory analysis of HELIOS-A and the

00:00:00

Deep Learner: Building AI to Improve Cardiovascular Care

Cardiology ·

2024/04/12

Guest: Pierre Elias, MD In this episode, you’ll gain insights into Dr. Elias’ innovative approach, integrating technology, data science, and medicine to develop algorithms that aim to enhance accuracy in predicting cardiovascular disease while allowing them to focus on providing personalized care to their patients. This could even help diagnose patients before symptoms occur. Join health and science journalist Catherine Price as she speaks with Dr. Pierre Elias, Medical Director of

00:00:00

Semaglutide Reduces CV Events in Non-Diabetic,...

Cardiology ·

2024/04/08

Host: Carol Wysham, MD Guest: A. Michael Lincoff, MD Given the growing evidence that obesity is associated with increased cardiovascular risk, a recent study assessed the impact of semaglutide on cardiovascular outcomes in patients who are overweight or obese but do not have diabetes. Not only did semaglutide reduce the risk of cardiovascular death, myocardial infarction, and stroke by 20 percent, but it also significantly reduced the risk of developing diabetes. Dive further into

00:00:00

Beyond BeAT-HF: Integrating Barostim into a...

Cardiology ·

2024/04/05

Host: Dmitry M. Yaranov, MD During the clinical course of heart failure, even with guideline directed medical therapy, many patients still experience symptoms that negatively impact their quality of life. Baroreflex activation therapy, or BAT, is an FDA approved therapy for patients with heart failure with reduced ejection fraction that has been shown to improve patient’s functional status, exercise capacity, and quality of life. Let's review how we may be able to expand the window of

00:00:00

Against the Odds: Improving Survival for Children...

Cardiology ·

2024/04/05

Guest: Christopher Petit, MD Pulmonary vein stenosis (PVS) is a rare and challenging heart condition, which narrows blood vessels around the lungs and typically impacts newborn children. Historically, the rates of survival have been low, but with Dr. Petit leading the development of innovative techniques and treatments, the trajectory of patients’ lives could positively change. Join health and science journalist Catherine Price and Dr. Christopher Petit, Co-Director of Children’s Heart

00:00:00

What Are the 10 Key Takeaways for the 2023...

Cardiology ·

2024/03/15

Host: Manesh R. Patel, MD The recently published 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines are based on systematic methods to evaluate and classify evidence and provide a foundation for the delivery of quality cardiovascular care. This program will help distill these valuable clinical guidelines to help healthcare

00:00:00

Case Study - New Guideline Recommendations into...

Cardiology ·

2024/03/15

00:00:00

How Do We Best Incorporate Latest Guidance in...

Cardiology ·

2024/03/15

Host: Sean Pokorney, MD The recently published 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines are based on systematic methods to evaluate and classify evidence and provide a foundation for the delivery of quality cardiovascular care. This program will help distill these valuable clinical guidelines to help healthcare

00:00:00

Impact of Social Determinants of Health on Management...

Cardiology ·

2024/03/15

Host: Kevin Thomas, MD The recently published 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines are based on systematic methods to evaluate and classify evidence and provide a foundation for the delivery of quality cardiovascular care. This program will help distill these valuable clinical guidelines to help healthcare

203 results

Cardiology

All Episodes

Similar Podcasts

科学史评话最新专辑

科学史评话

Hablando con Científicos - Cienciaes.com

cienciaes.com

天方烨谈

基因频道

The Permaculture Podcast

Scott Mann

汪诘：科学有故事（主打）

科学有故事